跳至主要内容
临床试验/TCTR20200622006
TCTR20200622006进行中(未招募)2 期

Efficacy of soy isoflavone product on hot flushes symptoms in surgical menopausal women

Chiang Mai University0 个研究点目标入组 50 人开始时间: 2020年6月22日最近更新:
适应症

试验速览

阶段
2 期
状态
进行中(未招募)
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 Years 至 0 N/A (No limit)(—)
性别
Female

入选标准

  • 1. Surgical menopause (6 weeks postsurgical bilateral oophorectomy with or without hysterectomy).
  • 2. Age >30 years.
  • 3. Serum follicle-stimulating hormone concentration >35 IU/L.
  • 4. Average of five or more hot flush symptoms per day.

排除标准

  • 1. History of chronic renal, liver, pulmonary, cardiovascular or gastrointestinal diseases, thromboembolic disorders, thyroid disease and a history of cardiovascular disease or stroke.
  • 2. Recent cigarette smoking or alcoholic consumption.
  • 3. History of substance abuse or addiction.
  • 4. Use of HRT or oral contraceptives in the past 6 months.
  • 5. Intake of nutritional supplements containing vitamins, minerals, fibers and isoflavones within the previous 2 weeks.
  • 6. Allergy or hypersensitivity to soy or cow milk.

研究者

相似试验